We use first-party cookies to provide you the best possible experience. Necessary By clicking "Accept", you agree to the use of our cookies on your device. By clicking "Decline", you can continue Browse but certain features may be limited.

World's largest AI powered Drug Assets Manager

Our Business

Asset Management

Capital Gains Through AI‑Driven Asset Selection Strategically in-licensed three high-potential oncology assets, selected through Partex proprietary platform and scientific validation to deliver maximum ROI and transformative market impact

Asset Exchange

Partnership Share Through Drug Lifecycle with AI Transforming drug licensing through AI — enabling asset indication repositioning and smarter clinical roadmaps for partners. Its equity-for-AI model fuels next-gen discovery programs with innovators driving breakthrough therapies forward.

Asset Services- Enabler

Empowering clinical development decisions across the industry through our advanced Technology Stack, Data, and Real World Lab Validation

Our solution background image

Our Solution

Revolutionize drug discovery and development, eliminating inefficiencies with Big Data and Artificial Intelligence — accelerating the path to better therapies for patients

Who We Partner With

Flask

Academics

Pharma icon

Biotechs

CRO icon

CROs

Academic icon

Hospitals

Patient icon

Pharma

We work with top players in the Life Sciences industry from across
the world to bring new drugs to patients faster

Board Members

Francisco Fernandez's photo

Francisco
Fernandez

Founder & Chairman

Dr. Gunjan-Bhardwaj.jpeg's photo

Dr. Gunjan
Bhardwaj

Founder & CEO

Dr. Keren Paul Zimmer's photo

Dr. Karen Paul
Zimmer, MD, MPH

Board Member

ontosight ad illustration

Ontosight®

FREE for a limited time

Try now